Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Vicente Guillem Porta"'
1
Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain
Autor: Enrique Gallardo, Carlos Camps, Aranzazu Gonzalez del Alba, Álvaro Pinto Marín, Vicente Guillem Porta, Javier Puente, María José Méndez Vidal, Miguel Angel Climent Duran, Álvaro Rogado, Francisco J. Campos-Lucas, Cristina Antón-Rodriguez, Martín Lázaro-Quintela, Ilse Lugo, Fernando Caballero-Martínez, Ignacio Duran
Publikováno v: Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 24(3)
To review current measures for renal cancer care and develop a comprehensive and updated list of measures for their practical use in Spain. The study was developed by Fundacion ECO, a Spanish foundation aiming to improve oncology quality of care. A s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e9e745880942c7886079574a9ed6119
https://pubmed.ncbi.nlm.nih.gov/34482526
Zobrazit plný text záznamu
2
The Economic Burden of Localized Prostate Cancer and Insights Derived from Cost-Effectiveness Studies of the Different Treatments
Autor: David Cantarero-Prieto, Javier Lera, Paloma Lanza-Leon, Marina Barreda-Gutierrez, Vicente Guillem-Porta, Luis Castelo-Branco, Jose M. Martin-Moreno
Publikováno v: Cancers, 2020, 14(17), 4088
Prostate cancer has huge health and societal impacts, and there is no clear consensus on the most effective and efficient treatment strategy for this disease, particularly for localized prostate cancer. We have reviewed the scientific literature desc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb431c09fde9233cee19f144917141f6
https://doi.org/10.3390/cancers14174088
Zobrazit plný text záznamu
3
Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy
Autor: Sergio Sandiego, Abraham Hernandez, Ana Calatrava, Vicente Guillem-Porta, Carmen Herrero-Vicent, Joaquín Gavilá, Maria Asunción Algarra, Ángel L Guerrero, Amparo Ruiz-Simon, Francisco Gozalbo
Publikováno v: ecancermedicalscience
Introduction In locally and locally advanced triple-negative breast cancer (TNBC), neoadjuvant chemotherapy (NAC) only induces a pCR in 30-35% of patients. Clinical and pathological factors are not enough to distinguish the patients who have no chanc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee254bbd69706f83dedc47d85369d877
https://doi.org/10.3332/ecancer.2017.759
Zobrazit plný text záznamu
5
A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
Autor: Angel Guerrero-Zotano, Amparo Ruiz-Simon, J Gavilá-Gregori, S Sandiego-Contreras, Carmen Herrero-Vicent, A Hernández-Blanquisett, Vicente Guillem-Porta, JM Samper-Hiraldo
Publikováno v: ecancermedicalscience
Background The appropriate selection criteria for breast-conserving surgery (BCS) or mastectomy after neoadjuvant chemotherapy (NAC) are poorly defined. The aim of this study is to analyse the incidence and prognostic factors for locoregional recurre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e53f16473ea2525ef201fe647c80eec
https://doi.org/10.3332/ecancer.2016.647
Zobrazit plný text záznamu
6
Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[+] operable breast cancer
Autor: Antonio Llombart-Cussac, E Buch, Amparo Ruiz, Vicente Guillem Porta, Álvaro Rodríguez-Lescure, Angel Guerrero, Antonio Galán, Carlos Fuster Diana, Vicente Carañana
Publikováno v: Clinical and Translational Oncology. 14:125-131
Letrozole is superior to tamoxifen in terms of response and breast preservation rates as primary systemic therapy (PST) in postmenopausal women with ER-positive early breast cancer. However, the optimum duration of endocrine PST remains uncertain.A p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::850e78e23c4b659fe7e2834ef9b0a6fc
https://doi.org/10.1007/s12094-012-0771-9
Zobrazit plný text záznamu
8
Breast cancer in pregnancy: an institutional experience
Autor: Joaquín Gavilá Gregori, Carmen Herrero Vicent, Abraham Hernández Blanquisett, Amparo Ruiz Simón, Vicente Guillem Porta, Angel Guerrero Zotano
Publikováno v: ecancermedicalscience
Background Breast cancer is one of the most common cancers diagnosed during pregnancy. Pregnancy-associated breast cancer (PABC) is defined as breast cancer diagnosed during pregnancy or within 12 months of delivery. Nowadays PABC can be safely diagn
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7eed74e9bd56fc8e5945c594769765
http://europepmc.org/articles/PMC4531131
Zobrazit plný text záznamu
9
Anti-emetic efficacy of oral granisetron in the total control of late-onset emesis induced by cyclophosphamide-containing chemotherapy
Autor: Julio Rifá Ferré, Isidro Barneto Aranda, A. Luque, Álvaro Rodríguez-Lescure, Javier Martín-Broto, Vicente Guillem Porta, Rafael López-López, S. Dominguez, Amalia Gómez-Bernal, Enrique Aguilar, Virtudes Soriano Teruel, Alfredo Carrato Mena
Publikováno v: Revista de Oncología. 6:22-29
Effectiveness of 5-HT3 receptor antagonists in preventing cyclophosphamide-induced emesis suggests that it is mediated by serotonin release. Since urinary 5-hydroxyindoleacetic acid (5-HIAA) is not significantly increased, the mechanism of emesis ind
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::720ff2dd4b5760974d479c1f7ed3937a
https://doi.org/10.1007/bf02710298
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje